PMC:7234792 / 4170-4321 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"90","span":{"begin":12,"end":24},"obj":"Chemical"},{"id":"91","span":{"begin":68,"end":79},"obj":"Chemical"}],"attributes":[{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"MESH:D017963"},{"id":"A91","pred":"tao:has_database_id","subj":"91","obj":"MESH:D002981"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Intravenous azithromycin (500 mg once a day) was restarted and oral clindamycin (300 mg once every 6 h) was administered, without clinical improvement."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T65","span":{"begin":38,"end":39},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Intravenous azithromycin (500 mg once a day) was restarted and oral clindamycin (300 mg once every 6 h) was administered, without clinical improvement."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T44","span":{"begin":12,"end":24},"obj":"Chemical"},{"id":"T45","span":{"begin":68,"end":79},"obj":"Chemical"}],"attributes":[{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_3745"}],"text":"Intravenous azithromycin (500 mg once a day) was restarted and oral clindamycin (300 mg once every 6 h) was administered, without clinical improvement."}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Intravenous azithromycin (500 mg once a day) was restarted and oral clindamycin (300 mg once every 6 h) was administered, without clinical improvement."}